Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Otsuka Holdings Co., Ltd.
  6. News
  7. Summary
    4578   JP3188220002

OTSUKA HOLDINGS CO., LTD.

(4578)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Otsuka : Announcement of Changes in Company Officers at Otsuka Pharmaceutical Co., Ltd.

12/12/2019 | 09:31am EDT

Otsuka Holdings Co., Ltd. and its subsidiary Otsuka Pharmaceutical Co., Ltd. announce that the changes described below have been made to the composition of company officers at Otsuka Pharmaceutical, pursuant to decisions by the boards of directors at Otsuka Holdings and at Otsuka Pharmaceutical on December 11 and December 9, respectively.

The change of company officers will be decided formally at the general shareholders meeting of Otsuka Pharmaceutical on March 10, 2020, and the subsequent board meeting.

Contact:

Tel: +81 (0)3-6717-1410

(C) 2019 Electronic News Publishing, source ENP Newswire

All news about OTSUKA HOLDINGS CO., LTD.
06/23TEVA PHARMACEUTICAL INDUSTRIES  : Secures Japanese Approval for Ajovy Injection ..
MT
06/09OTSUKA  : Complete Introduction of CO2-free Electricity for All 23 Manufacturing..
AQ
06/09Japanese electronics retailer Yamada to fully acquire furniture shop Otsuka K..
RE
06/08OTSUKA  : Complete Introduction of CO2-free Electricity for All 23 Manufacturing..
PU
06/02Decibel Therapeutics Names New Board Chairman
MT
06/01Akebia, Otsuka Say FDA Accepts New Drug Application for Anemia Drug Vadadusta..
MT
06/01OTSUKA  : and Akebia Announce U.S. FDA Acceptance for Filing of New Drug Applica..
PU
04/28OTSUKA  : Notice Concerning Completion of Payment for Disposal of Treasury Share..
PU
04/14NIKKEI 225  : Down 0.4% Amid Pandemic, Monthly Decline in Private Sector Core Ma..
MT
04/14Otsuka Holdings to Continue Phase III Trial of Brexpiprazole; Shares Fall 5%
MT
More news
Financials
Sales 2021 1 428 B 12 895 M 12 895 M
Net income 2021 149 B 1 346 M 1 346 M
Net cash 2021 282 B 2 544 M 2 544 M
P/E ratio 2021 17,0x
Yield 2021 2,13%
Capitalization 2 565 B 23 137 M 23 159 M
EV / Sales 2021 1,60x
EV / Sales 2022 1,51x
Nbr of Employees 33 151
Free-Float 75,8%
Chart OTSUKA HOLDINGS CO., LTD.
Duration : Period :
Otsuka Holdings Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OTSUKA HOLDINGS CO., LTD.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Last Close Price 4 729,00 JPY
Average target price 4 637,50 JPY
Spread / Average Target -1,93%
EPS Revisions
Managers and Directors
NameTitle
Tatsuo Higuchi President, CEO & Representative Director
Yuko Makino Chief Financial Officer & Director
Ichiro Otsuka Chairman
Yukitakeshi Matsutani Independent Outside Director
Yasushi Sekiguchi Independent Outside Director
Sector and Competitors